Viridian Therapeutics, Inc. (VRDN) came out with a quarterly loss of $1.15 per share versus the Zacks Consensus Estimate of a loss of $1.11. This compares to loss of $1.09 per share a year ago.

Viridian Therapeutics ( (VRDN)) has issued an update. Viridian Therapeutics, a biotech company, highlights its recent advancements in treating thyroid eye disease (TED) and FcRn inhibitor ...

Social Security benefits are eligible for an increase in 2025. The average monthly benefit is expected to rise by about $50. Since the cost of Medicare Part B is going up, retirees who are ...

My team and I put the best laser engravers to the test - and these are the models we recommend for home crafting, hobbyists, and professionals. Like the best 3D printers we've reviewed ...

The HP LaserJet M209d is a sterling value among low-cost, print-only mono laser printers. (If you're considering an inkjet but print only occasionally, it's a tempting alternative.) Its paper ...